Skip to main content
Clinical Trials/ACTRN12611000525987
ACTRN12611000525987
Recruiting
未知

An observational study of bariatric surgery on adiponectin expression, circulation and receptor number in obese patients.

The Univeristy of Auckland0 sites45 target enrollmentMay 23, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Obesity
Sponsor
The Univeristy of Auckland
Enrollment
45
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 23, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
The Univeristy of Auckland

Eligibility Criteria

Inclusion Criteria

  • Phase 1 A Lean: BMI 18\.5\-25 kg/m2, weight stable and healthy.
  • Accepted into the Auckland District Health Board Auckland City Hospital General Laparoscopic Upper GI Surgery Clinic. Accepts reversion to open surgery if necessary.
  • Signed informed consent given.
  • Phase 1 B Obese: BMI \>40 or \>35 kg/m2 with co\-morbidities and weight stable.
  • Accepted into the Auckland District Health Board Auckland City Hospital General Laparoscopic Upper GI Surgery Clinic. Accepts reversion to open surgery if necessary.
  • Signed informed consent given.
  • Phase 2: Body Mass Index (BMI) \>40 kg/m2 or \>35 kg/m2 plus co\-morbidities of diabetes, polycystic ovary syndrome, fatty liver disease and severe dyslipidaemia.
  • Accepted for Bariatric Surgery at Auckland City Hospital
  • Signed informed consent given

Exclusion Criteria

  • History of inflammatory or malignant disease.
  • Previous obesity surgery – bariatric, liposuction, lipectomy or liposculpture
  • Pregnant or breastfeeding
  • Participation in another clinical trial
  • No weight loss medication of weight programme attendance.
  • No extreme food restriction and/or excessive physical activity and alters body composition in a short space of time.

Outcomes

Primary Outcomes

Not specified

Similar Trials